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Abstract: Stuttering is a speech disorder, with onset often occurring in the preschool years. 
The prevalence of stuttering in young children is much higher than that in the general popu-
lation, suggesting a high rate of recovery. However, we are unable to predict which children 
will recover without treatment, and it is widely acknowledged that stuttering therapy during 
childhood provides the best safeguard against chronic stuttering. This review reports on current 
evidence-based stuttering treatment options for preschoolers through to adolescents. We discuss 
the clinical challenges associated with treating pediatric clients who stutter at different stages 
of development and explore potential areas of treatment research that might serve to advance 
current clinical practice in the future.
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Introduction
Stuttering is most likely the result of disturbances in the neural timing required for 
speech production.1–4 Although genetic studies have found some chromosomal link-
age to stuttering within family and twin studies, these links have been found to be 
inconclusive as causative.5 There are many causal theories about stuttering, which 
have provided underpinnings for treatment options; however, none have been empiri-
cally validated. The onset of stuttering usually occurs between 2 years and 4 years of 
age, coinciding with a time of rapid language development. Although the incidence 
of stuttering in preschool children may be as high as 11%,6 natural recovery is likely 
to occur in approximately two-thirds of cases.7 Some authors have alluded to possible 
factors that foreshadow persistent stuttering;8–11 however, prognostic indicators have 
not been clearly established, and we cannot predict who will recover from stuttering 
without intervention. Early intervention offers the best chance of ameliorating stut-
tering. However, the uncertainty regarding natural recovery; the significant changes 
that occur in cognition, physiology, behavior, and communication during childhood; 
and the reducing tractability as the child ages mean that treatment in the pediatric 
population is complex. This review explores stuttering treatments for preschoolers, 
school-age children, and adolescents with a focus on those with the most recent and 
compelling evidence base. We critically reflect on current challenges in the manage-
ment of pediatric stuttering and discuss how these challenges might best direct future 
research.
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Treatment options for preschoolers
The most efficacious options for early stuttering intervention 
are parent delivered, with the clinician playing the role of a 
facilitator. Intervention for preschool children who stutter 
can be broadly divided into two categories: 1) direct treat-
ments, ie, intervention directly targeting the amelioration of 
stuttering and 2) multifactorial treatments, ie, approaches that 
address multiple factors in the child’s environment presumed 
to be triggers for stuttering. 
Direct treatments
Direct treatments focus on the elimination of stuttering and 
the maintenance of stutter-free speech. Treatment goals and 
procedures are determined by fluency progress. Theoreti-
cally, reductions in stuttering are believed to occur because 
of operant methods, motoric practice of stutter-free speech, 
or a combination of these two elements.
The Lidcombe Program
The Lidcombe Program12 is arguably the most extensively 
researched treatment for early stuttering. The efficacy of this 
intervention has been demonstrated in several randomized 
controlled trials (RCTs),13–16 clinical audits,17–19 and investiga-
tions on group20 and telehealth16,21,22 service models. Further 
evidence of the effectiveness of the Lidcombe Program 
comes from case and small group studies from around the 
globe15,23–27 and a community translation study.28
The Lidcombe Program involves treatment sessions 
where the parent provides responses known as verbal con-
tingencies to the child’s stuttered and stutter-free speech. 
As the child’s stutter-free speech increases, the treatment 
conversations become less structured and the verbal 
contingencies are administered in general conversation 
across the day. The Lidcombe Program guide is available 
online;12 however, further professional development is 
recommended.
The Westmead Program
The Westmead Program is a treatment based on rhythmic 
or syllable-timed speech. This program uses a technique 
reported to have been used to “cure” stuttering as far back as 
fourth century BCE.29 The child is taught a speech pattern that 
gives every syllable the same duration, and parents facilitate 
the practice of syllable-timed speech several times daily. 
Early studies investigating this technique used a metronome 
to enable even syllabic lengths in speech30 but this has been 
deemed no longer necessary to achieve treatment outcomes. 
Treatment procedure information is limited to appendices in 
published trial articles31–33 and one book chapter.34 Clinical 
studies have reflected successful fluency outcomes, but more 
research is required to determine the long-term outcomes and 
optimal treatment procedures.
Multifactorial treatments
In multifactorial approaches, treatment aims to address 
environmental factors believed to be associated with stutter-
ing and to reduce stuttering.35 The theoretical basis derives 
from the “Demands and Capacities Model” (DCM).36–39 This 
theory attributes the onset of early stuttering to the child’s 
diminished capacity to produce fluent speech when faced 
with environmental, linguistic, emotional, and/or cognitive 
demands.39 Treatment focuses on changing parent behaviors 
and family routines that are likely to decrease these demands. 
Multifactorial treatments are often referred to as “indirect” 
because treatment targets do not directly address stuttering 
behaviors.
Palin parent–children interaction therapy
Palin parent–child interaction therapy (PCIT) was developed 
in the UK at the Michael Palin Centre for Stammering.40 
In this treatment, parents are observed interacting with the 
child who stutters and given strategies to target in 15-minute 
conversations, several times a week. Parent targets include 
reducing parental speech rate, following the child’s lead and 
pace in play, turn taking, increasing praise, and using com-
ments over questions in conversation.41,42 Treatment may also 
involve addressing factors related to child behavior manage-
ment, sleeping patterns, and family routines.41 Although PCIT 
is primarily indirect, if family strategies do not bring about 
a reduction in stuttering, parents may be instructed to use 
direct strategies, eg, prompting the child to slow their speech 
rate or pause more frequently in treatment activities.41 PCIT 
has been developed over the last two decades, with favorable 
outcomes reported in a handful of well-designed, but small 
group studies.43–45
RESTART-DCM
RESTART-DCM is a treatment developed in the Netherlands 
directly based on the DCM approach, following the publica-
tion of a Dutch translation of Starkweather et al’s46 clinical 
method in 1990. This approach involves facilitating changes 
in linguistic, motoric, emotional, and cognitive aspects of 
the child and the child’s environment.47 Treatment efficacy 
has been tested in two studies; a small 12-week experiment48 
and a randomized trial of 199 participants.24 In both studies, 
DCM treatment was compared with the Lidcombe Program, 
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with the latter study finding little difference in therapeutic 
outcomes between the two approaches after 18 months. The 
RESTART-DCM treatment manual is publicly available 
online;47 however, the authors recommend further training 
prior to administering treatment.
Treatment options for school-age 
children
Effective management of stuttering in children from early 
school age to late adolescence requires consideration of many 
factors including stuttering severity, stuttering tractability, 
and the child’s developmental stage. For younger school-age 
children, research has predominantly focused on adapta-
tions of stuttering treatments for preschoolers. According 
to developmental psychology, from the age of ~12 years 
children shift from a desire to master short-term goals and 
gain parental approval to a focus on performance-related 
peer conformity;49 therefore, treatment research for this age 
group tends to focus on adult treatment studies that include 
adolescent participants.
Early school-age stuttering management
The Lidcombe Program for school-age children (6–12 years) 
has been investigated in two Phase I trials,50,51 with a total 
of 23 children. Both trials reported successful outcomes for 
the majority of school-age children; however, greater vari-
ability of treatment outcomes was observed when compared 
with preschooler studies. Similarly, in a Phase I Westmead 
Program trial of ten school-age children (6–11 years),52 all 
but two children made reductions in stuttering severity. Once 
again, there was notable variability between participants, 
and only one participant was assessed as stutter-free after 
9 months of treatment.
Adolescent stuttering management
The Camperdown Program
Recent treatment studies with adolescents who stutter have 
focused on variants of speech restructuring. This involves 
the practice of a new speech pattern to replace stuttered 
speech, usually by slowing speech (prolonged speech) or 
using techniques to alter the way speech is delivered to 
overcome moments of stuttering (fluency shaping). The 
Camperdown Program is one such treatment for adults, with 
efficacy reflected in Phase I and II trials.53–56 In this treatment, 
through regular practice and by gradually increasing the 
naturalness of the prolonged speech technique, the speaker 
is able to control stuttering in everyday conversations. The 
 Camperdown  Program has been tested in Phase I and II 
trials with children aged from 12 years to 17 years, with 
the majority of participants treated using webcam delivery. 
Findings revealed overall reductions in stuttering severity, 
but variability in efficiency of treatment effect.57–59
Comprehensive Speech Program
Evidence to support the Comprehensive Speech Program as 
a treatment for adolescents comes from adult trials including 
a small number of adolescent participants.60,61 This program 
not only focuses on speech restructuring in order to reduce 
stuttering behaviors but also addresses goal setting and deal-
ing with attitudinal responses to stuttering. The developers 
anecdotally cite over two decades of success using this pro-
gram and adaptations of it for early school-age children;62 
however, more research is recommended to determine the 
efficacy for this population.
Time-out and self-imposed time-out
“Time-out” and a variant “self-imposed time-out” have been 
investigated in studies of adults and adolescents from the age 
of 14 years.63,64 As in the Lidcombe Program, this approach 
is based on the behavioral theory that responses contingent 
on stuttering behavior may play a role in stuttering reduction. 
In time-out, children are given a signal by their clinician or 
parent when they stutter, the child then stops speaking and 
pauses before continuing fluently. In self-imposed time-out, 
the onus is on the client to self-monitor and pause following 
the stuttering moment. Studies on this treatment show suc-
cess for some participants, but like other treatment options 
for early school-age and adolescent children, variability in 
treatment success is present.
Clinical challenges
Treat or monitor?
In the case of preschool children who stutter, the initial 
challenge for clinicians is to determine the optimal time to 
commence treatment considering the likelihood of natural 
recovery. Although stuttering frequency, severity and typol-
ogy, time since onset, family history, the impact on the child’s 
ability to communicate, and the child’s level of frustration 
or anxiety about the stutter are all considered during the 
assessment process, no one factor has been proven as causal 
or predictive. However, all these factors have been cited as 
potential markers of persistent stuttering.11
Generally, speech pathologists are likely to take a moni-
toring approach if stutter onset is within 6 months and stut-
tering is not adversely affecting the preschooler or parent.65 
Depending on the variables mentioned earlier and how close 
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the child is to school age, treatment may be delayed for up to 
12 months after stuttering onset without impacting on treat-
ment duration.18 To date, pretreatment severity is the only 
known predictor of treatment duration.17–19 Parent education 
about clinical challenges and prognosis is critical to ensure 
parents can participate in informed decision making regard-
ing starting treatment or monitoring stuttering.
Treatment dosage
The amount of treatment required to reduce or eliminate 
stuttering varies across the different programs discussed. 
Clinicians cannot predict with certainty the amount of clinic 
time or home practice required to achieve stutter-free speech. 
Although Lidcombe Program developers maintain that it 
is likely to take a median of 16 clinic visits for the child to 
achieve stutter-free speech, 10% of cases are likely to take 
>26 weeks,66 and little is known about those children who 
appear to be treatment resistant. One Westmead Program 
study cites a 96% mean reduction in stuttering with an aver-
age of clinical hours for participants to achieve little or no 
stuttering.32 However, over half of the participants withdrew 
from this study prior to achieving stutter-free speech, with 
the authors suggesting that the parental practice schedule 
may have been prohibitive in sustaining treatment adherence. 
In multifactorial treatments, PCIT visits occur weekly for 
6 weeks, and then at wider intervals, whereas RESTART-
DCM visits continue until the child’s speech is deemed 
acceptable by the clinician and parents.46 If the clinician 
administers either the Lidcombe or Westmead Programs 
within the parameters of evidence-based practice, the dosage 
is potentially much higher than that of PCIT and RESTART-
DCM in order to achieve the goal of stutter-free speech, as 
opposed to a mere reduction in stuttering. Regular home 
treatment practice can also be challenging, particularly when 
both parents work, if parents are separated, or when there 
are siblings, reducing the amount of time available. Private 
speech pathology fees are often costly and the financial 
burden for families also requires consideration. Likewise, 
clinicians face ethical dilemmas when they are unable to 
complete treatment as outlined in evidence-based research 
owing to fiscal and other workplace constraints.28,67,68
Concomitant diagnoses
The impact of cognitive, behavioral, and/or other speech and 
language disorders on treatment duration and procedure is 
largely unknown as treatment research methodologies often 
exclude children with other diagnoses to avoid confound-
ing variables. Nevertheless, there is evidence to suggest an 
increased likelihood of stuttering for children who have been 
diagnosed with other communication disorders,69,70 autism 
spectrum disorder,71 and Down syndrome.72
Recent discussion articles on this subject73,74 and one 
published case study on treatment for a school-age child with 
Down syndrome75 provide some directions for clinical man-
agement. These articles offer frameworks for determining 
appropriate treatment pathways depending on client charac-
teristics, mostly with a focus on hybrids of direct intervention 
strategies. However, clinicians must largely depend on their 
own clinical reasoning to determine treatment targets based 
on the child’s individual characteristics.
Access to professional development and 
treatment resources
For speech pathologists treating pediatric stuttering, access 
to resources and professional development (as recommended 
by all treatment developers) largely depend on where the cli-
nicians reside. The Lidcombe Program Trainers Consortium 
provides professional development on preschool treatment 
in ten countries. Training on the Lidcombe and Westmead 
Programs for school-age children is limited to Australia 
and New Zealand.76 PCIT training is available in the UK 
and – less frequently – in North America,40 and training 
for the RESTART-DCM program is currently limited to 
the Netherlands.46 This presents a challenge to clinicians 
in Australia and New Zealand, where opportunities for 
professional development in evidence-based multifacto-
rial treatments are either nonexistent or cost prohibitive. 
Nevertheless, as a companion to professional development, 
treatment guides are available for the Lidcombe Program 
and the Camperdown Program,12 a comprehensive text is 
available for PCIT,41 and more recently a RESTART-DCM 
treatment protocol has been made available online.46 The 
Westmead Program treatment literature is limited to brief 
descriptions of clinical procedures in clinical articles31–33 
and book chapters.34,65
Psychosocial consequences
Stuttering is associated with a range of psychosocial conse-
quences across the preschool and school-age years. These 
include negative evaluation by nonstuttering peers,77 stereo-
typing by teachers,78,79 and increased risk of being the victim 
of teasing and bullying.80–82 Exposure to negative social con-
sequences such as these has been identified as a risk factor 
for the development of anxiety. Indeed, adults who stutter 
are significantly more likely to have a diagnosis of social 
anxiety disorder than nonstuttering controls.83 The literature 
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is currently unclear as to when anxiety onset in stuttering 
occurs however, it is likely that the risk of anxiety increases 
as stuttering children approach adolescence and adulthood.84 
In lieu of evidence to guide clinical practice, clinicians must 
be cognizant of the potential impact of stuttering on mental 
health in the pediatric population and refer to a psychologist 
if necessary and appropriate.
Future directions
Stuttering treatment researchers are often divided about 
which components of stuttering treatment actively reduce 
stuttering in the pediatric population.42,85 For example, as a 
treatment tested in numerous randomized controlled experi-
ments,14,20,24,86 the Lidcombe Program is regarded as highly 
efficacious, but it is not known which components of this 
treatment reduce stuttering. A recent RCT suggests parity in 
the treatment effect between divergent Lidcombe Program 
and DCM approaches,24 but multifactorial treatments such 
as DCM carry multiple treatment components. Without 
supporting evidence to test component utility, some DCM 
components may be redundant. Recent Lidcombe Program 
studies have begun to reveal challenges to the long-held 
theoretical belief that operant mechanisms drive therapeutic 
success.86–89 Such discoveries are important, as knowledge 
about which components of a treatment are useful will 
enable ease of clinical problem solving and increase treat-
ment efficiency. Furthermore, such knowledge may assist 
in individualizing treatment to better serve individual cli-
ent differences associated with concomitant disorders and 
treatment-resistant cases.
Treatment process knowledge is also likely to reduce the 
variability in outcome success reflected in school-age and 
adolescent populations. Recent discussion in both pediatric 
stuttering and the field of psychology asserts that treatment 
efficacy solely based on RCTs when treatment mechanisms 
are unknown can only provide a justification for use90 – 
 particularly when behavior change is the desired outcome.91,92 
In the future, clinical practice will benefit from research 
methodologies that enable therapeutic agency to be revealed 
either by testing components directly or by revealing patterns 
of successful clinical processes through case series studies.
Conclusion
There are currently a number of stuttering treatments 
available for the pediatric population, but there are vary-
ing levels of evidence to support their success. Although 
the Lidcombe Program is the most extensively researched 
treatment for  preschool stuttering, studies comparing the 
Lidcombe Program with RESTART-DMC show similar 
treatment outcomes. For school-age children and adoles-
cents who stutter, therapies are predominately adaptations 
of treatments designed for preschools or adults who stutter. 
There is, however, a dearth of clinical trial investigations to 
support treatment efficacy of any treatment for school-age 
children and adolescents who stutter. Similarly, depending 
on the location of the clinician, poor access to professional 
development can limit clinican’s ability to become proficient 
in all treatment options.
Clinicians are faced with a number of challenges when 
servicing the pediatric population. These include complex 
decision making regarding optimal time to treat, lack of 
information on treating stuttering in those with concomitant 
disorders, and uncertainty regarding optimal therapy dosage 
and long-term outcomes. Future research needs to address 
these challenges and investigate the mechanisms underlying 
therapeutic success.
Overall, clinicians working in the field of stuttering can 
feel heartened that there are a range of treatment options 
available for pediatric stuttering, but special care is required 
when determining the most appropriate treatment for the 
individual child. Future research directed at the treatment 
process may serve to diminish current challenges and help 
to achieve the best possible outcomes for this population.
Disclosure
The authors report no conflicts of interest in this work.
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